ASH 2023: Analyzing IsKia Trial : vimarsana.com

The IsKia trial findings presented at ASH 2023 are highlighted by Dr Fonseca.

Related Keywords

, Conference Perspectives , Multiple Myeloma , Analyzing Iskia , American Society Of Hematology , Cash , Newly Diagnosed Multiple Myeloma , Triplet Therapy , Quadruplet Therapy , Perseus Trial , Daratumumab , Bortezomib , Lenalidomide , Dexamethasone , Mvrd ,